WEKO3
アイテム
Preclinical evaluation of ⁸⁹Zr-labeled human antitransferrin receptor monoclonal antibody as a PET probe using a pancreatic cancer mouse model.
https://repo.qst.go.jp/records/47118
https://repo.qst.go.jp/records/4711890938a38-aa27-4726-840e-5b00368c043d
Item type | 学術雑誌論文 / Journal Article(1) | |||||
---|---|---|---|---|---|---|
公開日 | 2015-04-28 | |||||
タイトル | ||||||
タイトル | Preclinical evaluation of ⁸⁹Zr-labeled human antitransferrin receptor monoclonal antibody as a PET probe using a pancreatic cancer mouse model. | |||||
言語 | ||||||
言語 | eng | |||||
資源タイプ | ||||||
資源タイプ識別子 | http://purl.org/coar/resource_type/c_6501 | |||||
資源タイプ | journal article | |||||
アクセス権 | ||||||
アクセス権 | metadata only access | |||||
アクセス権URI | http://purl.org/coar/access_right/c_14cb | |||||
著者 |
Sugyo, Aya
× Sugyo, Aya× B, Tsuji Atsushi× Sudo, Hitomi× Nagatsu, Kotaro× Koizumi, Mitsuru× Ukai, Yoshinori× Kurosawa, Gene× Zhang, Ming-Rong× Kurosawa, Yoshikazu× Saga, Tsuneo× 須尭 綾× 辻 厚至× 須藤 仁美× 永津 弘太郎× 小泉 満× 張 明栄× 佐賀 恒夫 |
|||||
抄録 | ||||||
内容記述タイプ | Abstract | |||||
内容記述 | Pancreatic cancer is aggressive and its prognosis remains poor; thus, effective therapy is urgently needed. Transferrin receptor (TfR) is highly expressed in pancreatic cancer and is considered to be a good candidate for molecular-targeted therapy. We radiolabeled and evaluated fully human anti-TfR monoclonal antibodies as a new PET probe for evaluating the biodistribution of the anti-TfR antibody in pancreatic cancer. | |||||
書誌情報 |
Nuclear medicine communications 巻 36, 号 3, p. 286-294, 発行日 2015-03 |
|||||
出版者 | ||||||
出版者 | Lippincott Williams & Wilkins | |||||
ISSN | ||||||
収録物識別子タイプ | ISSN | |||||
収録物識別子 | 0143-3636 | |||||
PubMed番号 | ||||||
識別子タイプ | PMID | |||||
関連識別子 | 25460304 |